Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock Value [Member]	Additional Paid-in Capital [Member]	Treasury Stock [Member]	Accumulated Translation Adjustment [Member]	Retained Earnings [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interest [Member]
Stockholders' equity rollforward
Cumulative effect adjustment	$ 352,561		$ 1,185	$ 425,648	$ (18,651)	$ (43,767)	$ (156,335)		$ 144,481
Beginning balance at Dec. 31, 2017	352,561		1,185	425,648	(18,651)	(43,767)	(156,335)		144,481
Stockholders' equity rollforward
Net loss	(61,617)						(61,617)
Net loss	(84,240)								(22,623)
Translation adjustment, net of taxes	(10,084)					(7,896)			(2,188)
Comprehensive loss	(94,324)
Distributions to public unitholders	(19,224)								19,224
Exercise of common stock options	274		23	251	0
Grants of restricted stock, net	(299)				(299)
Issuance of common stock for business combination	28,212		77	28,135
Equity compensation expense	7,165			6,715					450
Conversions of CCLP Series A Preferred	38,322								38,322
Cumulative effect adjustment	312,749	$ 2,843	1,285	460,680	(18,950)	(51,663)	(217,952)	$ 2,843	139,349
Other noncontrolling interests	62			69					131
Ending balance at Dec. 31, 2018	312,749	2,843	1,285	460,680	(18,950)	(51,663)	(217,952)	2,843	139,349
Stockholders' equity rollforward
Cumulative effect adjustment	312,749	2,843	1,285	460,680	(18,950)	(51,663)	(217,952)	2,843	139,349
Net loss	(147,413)						(147,413)
Net loss	(160,500)								(13,087)
Translation adjustment, net of taxes	(188)					(520)			332
Comprehensive loss	(160,688)
Distributions to public unitholders	(1,233)								1,233
Exercise of common stock options	(2)		(2)	0	0
Grants of restricted stock, net	(214)				(214)
Equity compensation expense	7,344			6,358					986
Conversions of CCLP Series A Preferred	2,539								2,539
Cumulative effect adjustment	312,749	$ 2,843	1,283	466,959	(19,164)	(52,183)	(362,522)	$ 2,843	128,453
Other noncontrolling interests	(512)			79					(433)
Ending balance at Dec. 31, 2019	162,826		1,283	466,959	(19,164)	(52,183)	(362,522)		128,453
Stockholders' equity rollforward
Cumulative effect adjustment	162,826		1,283	466,959	(19,164)	(52,183)	(362,522)		128,453
Net loss							(51,143)
Net loss	(98,933)								(47,790)
Translation adjustment, net of taxes	2,386					2,269			117
Comprehensive loss	(96,547)
Distributions to public unitholders	(1,244)								1,244
Grants of restricted stock, net	(320)				(320)
Issuance of common stock for business combination	6		6	0
Equity compensation expense	6,438			5,184					1,254
Cumulative effect adjustment	71,062		1,289	472,134	(19,484)	(49,914)	(413,665)		80,702
Other noncontrolling interests	(97)			9					(88)
Ending balance at Dec. 31, 2020	71,062		1,289	472,134	(19,484)	(49,914)	(413,665)		80,702
Stockholders' equity rollforward
Cumulative effect adjustment	$ 71,062		$ 1,289	$ 472,134	$ (19,484)	$ (49,914)	$ (413,665)		$ 80,702